Shafren, D., Quah, M., Wong, Y., Andtbacka, R. H., Kaufman, H. L., & Au, G. G. (2014). Combination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma model. J Immunother Cancer.

Shafren, Darren, Min Quah, Yvonne Wong, Robert HI Andtbacka, Howard L. Kaufman, a Gough G. Au. "Combination of a Novel Oncolytic Immunotherapeutic Agent, CAVATAK (coxsackievirus A21) and Immune-checkpoint Blockade Significantly Reduces Tumor Growth and Improves Survival in an Immune Competent Mouse Melanoma Model." J Immunother Cancer 2014.

Shafren, Darren, et al. "Combination of a Novel Oncolytic Immunotherapeutic Agent, CAVATAK (coxsackievirus A21) and Immune-checkpoint Blockade Significantly Reduces Tumor Growth and Improves Survival in an Immune Competent Mouse Melanoma Model." J Immunother Cancer 2014.